<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">SARS-CoV-2 primarily targets the lungs, the vasculatures, and the immune system [
 <xref ref-type="bibr" rid="CR33">33</xref>]. The initial step of the viral multiplication is the binding to the surface of respiratory cells mediated by the spike (S) viral protein [
 <xref ref-type="bibr" rid="CR34">34</xref>]. It had been speculated that SARS-CoV-2 likely utilize angiotensin- converting enzyme 2 (ACE2, EC 3.4.17.23) of various mammals, except murines and a few birds, such as pigeon [
 <xref ref-type="bibr" rid="CR35">35</xref>]. The affinity of SARS-CoV-2 for ACE2 is 10â€“20-higher than that of SARS- CoV [
 <xref ref-type="bibr" rid="CR36">36</xref>].
</p>
